Biomarkers Market

Biomarkers Market worth $53.3 billion by 2021

The Biomarkers Market is projected to reach USD 53.3 billion by 2021, at a CAGR of 13.8% during the forecast period.

In 2016, the market for biomarkers was valued at USD 28 billion. Some of the major factors driving the growth of this market include the growing applications of biomarkers in diagnostic procedures and the rising occurrence of cancer across the globe. In contrast to the drivers mentioned above, the high capital investments required for the discovery, development, and validation of biomarkers and technical issues related to sample collection & storage are some of the major factors restraining the growth of this market.

Browse 117 market data tables and 37 figures spread through 157 pages and in-depth TOC on "Biomarkers Market by Product (Consumables, Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, Cardiovascular Disorders), Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk) - Global Forecast to 2021"
View detailed Table of Content here -

The consumables segment commanded the largest share of the global biomarkers market in 2016

Based on the product, the biomarkers market is segmented into consumables, services, and software. The consumables segment accounted for the largest share of the biomarkers market in 2016. This product segment is also expected to grow at the highest CAGR during the forecast period. As consumables are comparatively more economical than screening and automation instruments, they are widely preferred by end users in this market.

In 2016, the safety biomarkers segment accounted for the largest share of the biomarkers market

Based on type, the biomarkers market has been categorized into safety, efficacy, and validation biomarkers. The safety biomarkers segment accounted for the largest share of the biomarkers market in 2016. The large share of this segment can be attributed to the fact that these biomarkers find widespread applications in drug development and discovery.

The diagnostics segment accounted for the largest market share of the biomarkers application market in 2016

Based on application, the biomarkers market is segmented into diagnostics, drug discovery & development, personalized medicine, disease risk assessment, and other applications (DNA fingerprinting, ecotoxicology, and forensics). The diagnostics segment accounted for the largest share of the market in 2016. The increasing prevalence of cancer, technologically developed biomarker products, and individualized treatments for cancer are some of the major factors driving the growth of this segment.

The cancer disease indication segment commanded the largest share of the market in 2016

Based on disease indication, the biomarkers market is categorized into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases (renal disorders, urinal diseases, diabetes, and tuberculosis). The cancer segment accounted for the largest share of the global biomarkers market in 2016. In recent years, the prevalence of cancer has increased across the globe, which, in turn, has increased the demand for cancer biomarkers. This is one of the major factors assisting the growth of this market segment. On the other hand, the biomarkers market for cardiovascular disorders is expected to register the highest growth during the forecast period.

Some of the prominent players operating in the biomarkers market are QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), Merck Millipore (US), Bio-Rad Laboratories, Inc. (US), and Enzo Biochem, Inc. (US).

Don’t miss out on business opportunities in Biomarkers Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
BT 2120
PR Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Biomarkers Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2021 MarketsandMarkets Research Private Ltd. All rights reserved

Digital Virtual Assistant - MarketsandMarkets